Omega-3 Fatty Acids: Bridging the Gap in Postpartum Depression Research

Postpartum depression (PPD) is a prevalent and debilitating condition affecting approximately one in seven women following childbirth. While the etiology of PPD is multifactorial, emerging evidence suggests a potential role for omega-3 polyunsaturated fatty acids in its prevention and management. This review critically evaluates current literature on the association between omega-3 supplementation and PPD, examining evidence regarding its effectiveness, potential mechanisms of action, and implications for clinical practice. A systematic search of electronic databases identified studies investigating omega-3 supplementation in relation to PPD outcomes. Findings suggest that higher omega-3 PUFA status during pregnancy may be associated with a reduced risk of PPD, though results from systematic reviews and meta-analyses remain inconclusive due to methodological variations and study limitations. Mechanistically, omega-3 polyunsaturated fatty acids (PUFAs) exert anti-inflammatory, neuroprotective, and mood-regulating effects, potentially mitigating PPD risk factors. However, further research, including meta-analyses of randomized controlled trials, is needed to elucidate the efficacy of omega-3 supplementation for PPD prevention and management.